Healthcare provider profile · identity verified

Andrew G Burt, MD

Family Practice · PENN VALLEY, CA · NPI 1902911845

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	492	164
Levothyroxine Sodium	Levothyroxine Sodium	488	146
Pravastatin Sodium	Pravastatin Sodium	455	149
Lisinopril	Lisinopril	431	137
Amlodipine Besylate	Amlodipine Besylate	289	98
Losartan Potassium	Losartan Potassium	272	90
Escitalopram Oxalate	Escitalopram Oxalate	193	63
Tamsulosin Hcl	Tamsulosin Hcl	186	64
Omeprazole	Omeprazole	164	58
Metoprolol Succinate	Metoprolol Succinate	159	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	142	42
Gabapentin	Gabapentin	126	40
Alendronate Sodium	Alendronate Sodium	103	40
Tramadol Hcl	Tramadol Hcl	103	29
Simvastatin	Simvastatin	97	33
Finasteride	Finasteride	91	27
Hydrochlorothiazide	Hydrochlorothiazide	91	32
Metformin Hcl Er	Metformin Hcl	86	29
Trazodone Hcl	Trazodone Hcl	86	30
Clopidogrel	Clopidogrel Bisulfate	82	30
Furosemide	Furosemide	82	28
Eliquis	Apixaban	81	23
Zolpidem Tartrate	Zolpidem Tartrate	74	25
Pantoprazole Sodium	Pantoprazole Sodium	73	25
Xarelto	Rivaroxaban	73	14
Synthroid	Levothyroxine Sodium	72	21
Ozempic	Semaglutide	67	13
Famotidine	Famotidine	65	23
Metformin Hcl	Metformin Hcl	63	20
Lorazepam	Lorazepam	62	27
Potassium Chloride	Potassium Chloride	61	25
Allopurinol	Allopurinol	58	18
Alprazolam	Alprazolam	51	28
Chlorthalidone	Chlorthalidone	51	18
Metoprolol Tartrate	Metoprolol Tartrate	51	16
Rosuvastatin Calcium	Rosuvastatin Calcium	50	19
Lovastatin	Lovastatin	48	12
Duloxetine Hcl	Duloxetine Hcl	46	15
Spironolactone	Spironolactone	42	15
Albuterol Sulfate Hfa	Albuterol Sulfate	41	24
Bupropion Xl	Bupropion Hcl	41	17
Benazepril Hcl	Benazepril Hcl	40	14
Carvedilol	Carvedilol	40	11
Fluticasone Propionate	Fluticasone Propionate	40	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	38
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	17
Montelukast Sodium	Montelukast Sodium	39	suppressed
Sertraline Hcl	Sertraline Hcl	39	15
Temazepam	Temazepam	39	suppressed
Prednisone	Prednisone	37	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	15
Incruse Ellipta	Umeclidinium Bromide	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Venlafaxine Hcl Er	Venlafaxine Hcl	33	11
Fluoxetine Hcl	Fluoxetine Hcl	31	11
Pregabalin	Pregabalin	30	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Clonazepam	Clonazepam	25	suppressed
Estradiol	Estradiol	25	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	13
Glipizide	Glipizide	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	11
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Primidone	Primidone	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	11
Digoxin	Digoxin	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	12
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Cephalexin	Cephalexin	13	13
Ezetimibe	Ezetimibe	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Atenolol	Atenolol	12	suppressed
Invokana	Canagliflozin	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error